| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 263,333 | 241,040 | 229,145 | 216,834 | | Cost of Revenue | 94,914 | 93,959 | 88,378 | 82,300 | | | Gross Profit | 168,419 | 147,081 | 140,767 | 134,534 | | | Operating Expenses | | Research Development | 32,071 | 28,584 | 27,766 | 31,013 | | Selling General and Administrative | 82,963 | 78,557 | 78,271 | 91,503 | | Non Recurring | 279 | 2,893 | 250 | 2,098 | | Others | 20,665 | 19,931 | 19,034 | 17,348 | | | | Total Operating Expenses | 135,978 | 129,965 | 125,321 | 141,962 | | | | Operating Income or Loss | 32,441 | 17,116 | 15,446 | (7,428) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,594 | (3,124) | 600 | 7,647 | | Earnings Before Interest And Taxes | 38,035 | 13,992 | 16,046 | 219 | | Interest Expense | 8,637 | 8,331 | 9,977 | 13,158 | | Income Before Tax | 29,398 | 5,661 | 6,069 | (12,939) | | Income Tax Expense | 23,108 | 6,670 | (998) | 11,611 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,290 | (1,009) | 7,067 | (24,550) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,290 | (1,009) | 7,067 | (24,550) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,290 | ($1,009) | $7,067 | ($24,550) |
|
0.51% Nasdaq 
Income Statement
